Listing 1 - 5 of 5 |
Sort by
|
Choose an application
The focus on dopamine-sensitive motor symptoms, in association with the improvement of motor complications in the heterogeneous disease entity Parkinson's disease, has led to a certain standstill in research. This Special Issue provides new concepts and new ideas on the pathogenesis, genetics, and clinical maintenance of Parkinson's disease and related disorders. Not only new experimental findings, but also clinical outcomes, case series, and research on alternative, non-pharmacological therapies are included. The objective is to bridge the currently increasing gap between experimental and clinical research on Parkinson's disease and related disorders.
microRNAs --- disease-modifying effects --- SH-SY5Y --- inpatient treatment --- sphingolipids --- neurodegeneration --- magnetic resonance spectroscopy --- MO3.13 --- schizophrenia --- epigenetics --- long-chain acylcarnitine --- molecular mimicry --- curli --- multimodal complex treatment --- chlorogenic acid --- glycerophospholipids --- caffeic acid --- lipoproteins --- myenteric plexus --- neurometabolites --- HOG --- immature oligodendrocyte --- autophagy --- oligodendrocyte --- hypochlorite --- alpha-synuclein --- microbiome --- glucocerebrosidase --- Lewy Body Dementia --- brain iron --- mesenchymal stem cells --- fatty acid ?-oxidation --- GABA --- enteric glial cell --- gut-brain axis --- microbiota --- REM sleep behavior disorders --- redox cycling --- magnetic resonance imaging --- differentiation --- ?-synuclein-mediated pathology --- Parkinson disease --- Gaucher’s disease --- metallothionein --- [123I]FP-CIT-SPECT --- dopaminergic neuron --- mature oligodendrocyte --- glycerolipids --- spectroscopy --- neuroinflammation --- exosomes --- immunotherapy --- DNA methylation --- sterol lipids --- nigral cells --- cell line --- cysteinyl-dopamine --- myelin --- parkinsonisms --- multiple sclerosis --- rotenone --- brain --- fatty acyls --- Krabbe’s disease --- neuroprotection --- DAT --- motor dysfunction --- secretome --- multiprofessional therapy --- Parkinson’s disease --- oxidative stress --- alpha-Synuclein
Choose an application
Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) are in vivo molecular imaging methods which are widely used in nuclear medicine for diagnosis and treatment follow-up of many major diseases. These methods use target-specific molecules as probes, which are labeled with radionuclides of short half-lives that are synthesized prior to the imaging studies. These probes are called radiopharmaceuticals. The use of PET and SPECT for brain imaging is of special significance since the brain controls all the body’s functions by processing information from the whole body and the outside world. It is the source of thoughts, intelligence, memory, speech, creativity, emotion, sensory functions, motion control, and other important body functions. Protected by the skull and the blood–brain barrier, the brain is somehow a privileged organ with regard to nutrient supply, immune response, and accessibility for diagnostic and therapeutic measures. Invasive procedures are rather limited for the latter purposes. Therefore, noninvasive imaging with PET and SPECT has gained high importance for a great variety of brain diseases, including neurodegenerative diseases, motor dysfunctions, stroke, epilepsy, psychiatric diseases, and brain tumors. This Special Issue focuses on radiolabeled molecules that are used for these purposes, with special emphasis on neurodegenerative diseases and brain tumors.
SV2A --- SV2B --- SV2C --- microPET --- [18F]UCB-H --- epilepsy --- PBIF --- distribution volume --- blocking assay --- preclinical imaging --- Alzheimer’s disease (AD) --- network measure --- graph theory --- brain network --- positron emission tomography (PET) --- persistent homology --- Phosphodiesterase 2A (PDE2A) --- Positron Emission Tomography (PET) --- Benzoimidazotriazine (BIT) --- fluorinated --- Mouse Liver Microsomes (MLM) --- cyclic nucleotide phosphodiesterase --- PDE2A radioligand --- nitro-precursor --- fluorine-18 --- in vitro autoradiography --- PET imaging --- opioid receptors --- positron emission tomography --- radiotracers --- μOR-, δOR-, κOR- and ORL1-ligands --- movement disorders --- pain --- drug dependence --- GBM --- biomarkers --- Sigma 1 --- Sigma 2 --- PD-L1 --- PARP --- IDH --- Alzheimer’s disease --- Parkinson’s disease --- β-amyloid plaques --- neurofibrillary tangles --- α-synucleinopathy --- diagnostic imaging probes --- orexin receptors --- PET --- radiotracer --- imaging --- alpha 7 --- nicotinic acetylcholine receptors --- nAChR --- autoradiography --- amino acid --- FET --- FACBC --- FDOPA --- immunoPET --- molecular imaging --- glioma --- brain metastases --- adenosine A2A receptor --- rotenone-based mouse model --- [18F]FESCH --- two-step one-pot radiosynthesis
Choose an application
This book is a collection of 12 peer-reviewed articles on freshwater invasive fish and is the first on this topic. It focuses on real-world lessons learned from managing common carp, bigheaded carp, sea lamprey, northern pike, and lake trout in different parts of the world. Articles also discuss damage caused by invasive fish, environmental DNA as means to measure spawning carp, and CO2 as a fish deterrent. Detailed critical evaluations of the possibility of using koi herpes virus to control common carp, market-driven fishing (invasivorism), as well as changes in lock and dam operating protocols to control bigheaded carps are also presented. Several important commonalities are noted between successful management efforts, including the simultaneous use of multiple integrated strategies, a focus on suppressing reproduction, and a deep local knowledge in an introductory article that provides context for the discipline.
suppression --- eradication --- rotenone --- fishery restoration --- northern pike --- salmon --- biocontrol --- Australia --- common carp --- Cyprinus carpio --- cyprinid herpesvirus 3 --- safety --- efficacy --- modelling --- risks --- adaptive management --- cutthroat trout --- ecosystem restoration --- nonnative fish suppression --- national park --- lake trout --- native species recovery --- Oncorhynchus --- predatory fish invasion --- Salvelinus --- trophic cascade --- wilderness preserve --- invasive species --- bigheaded carp --- biodiversity --- behavior --- physiology --- toxicity --- avoidance --- aquatic invasive species --- reservoir ecosystems --- ichthyoplankton --- Asian carp --- invasivorism --- commercial fishing --- Hypophthalmichthys --- Illinois River --- interference competition --- exploitative competition --- ruffe --- yellow perch --- growth --- diet --- integrated pest control --- source-sink --- sustainable --- micro-predators --- water quality --- population suppression --- lampricide --- sea lamprey --- Lake Champlain --- invasive --- incursion --- alien fish --- fyke net --- pest fish --- Lake Sorell --- Lake Crescent --- biotelemetry --- integrated pest management --- model --- hydraulic --- acoustic deterrent --- invasive fish --- conservation --- eDNA
Choose an application
Neurodegenerative diseases, including Alzheimer’s, Parkinson’s, Huntington’s, and amyotrophic lateral sclerosis, are the most common pathologies of the central nervous system currently without a cure. They share common molecular and cellular characteristics, including protein misfolding, mitochondrial dysfunction, glutamate toxicity, dysregulation of calcium homeostasis, oxidative stress, inflammation, and ageing, which contribute to neuronal death. Efforts to treat these diseases are often limited by their multifactorial etiology. Natural products, thanks to their multitarget activities, are considered promising alternatives for the treatment of neurodegeneration. This book deals with two different forms of natural products: extracts and isolated compounds. The study of the bioactivity of the extracts is extremely important as many studies have demonstrated the synergistic effect of the combination of different natural products. On the other hand, the investigation of the activity of specifically isolated natural products can be also important to understand their cellular and molecular mechanisms and to define the specific bioactive components in extracts or foods. This book can be considered an important contribution to knowledge of the neuroprotective effect of natural products and presents a great deal of information, related to both the benefits but also the limitations of their use in counteracting neurodegeneration.
Vitamin D --- Multiple Sclerosis --- symptom --- neurodegeneration --- oxidative injury --- Parkinson’s disease --- terpenes, rotenone --- thymol --- Alzheimer’s disease --- Centella asiatica --- hippocampus --- protein poshophatase 2 --- glycogen synthase kinase 3 --- B-cell lymphoma 2 --- neuroprotection --- nutraceuticals --- bioavailability --- stress response --- neurodegenerative disease --- bioactive compound --- natural extract --- β-amyloid peptide --- tau protein --- clinical trial --- human studies --- animal studies --- in vitro studies --- curcumin --- free radicals --- heme oxygenase --- safety profile --- type 2 diabetes --- inflammation --- vascular damage --- learning --- memory --- natural compound --- oxidative stress --- cognitive dysfunction --- cell death --- synapse loss --- protein aggregation --- neuroinflammation --- algae --- seaweeds --- neurodegenerative diseases --- auraptene --- dopamine neuron --- antioxidant --- mitochondria --- Chionanthus retusus --- flavonoid --- flower --- HO-1 --- NO --- Lippia citriodora --- VEE --- Vs --- relaxation --- depression --- cyclic AMP --- calcium --- blood–brain barrier --- catechin --- cognition --- epigallocatechin gallate --- green tea --- microbiota --- 5-(3,5-dihydroxyphenyl)-γ-valerolactone --- ascaroside pheromone --- C. elegans --- dauer --- neuronal signaling --- sexual behavior --- survival signals --- proteostasis --- chaperones --- autophagy --- ubiquitin-proteasome --- unfolded protein response --- natural compounds --- natural products --- ethics --- patients’ autonomy --- beneficence --- nonmaleficence --- medical liability --- Parkinson’s disease (PD) --- mitochondrial dysfunction --- dynamics --- hormesis --- ubiquitin‒proteasome system (UPS) --- mitophagy --- n/a --- Parkinson's disease --- Alzheimer's disease --- blood-brain barrier --- patients' autonomy --- Parkinson's disease (PD)
Choose an application
Continuous research advances have been observed in the field of environmentally-friendly polymers and polymer composites due to the dependence of polymers on fossil fuels and the sustainability issues related to plastic wastes. This book compiles the most recent research works in biopolymers, their blends and composites, and the use of natural additives, such as vegetable oils and other renewable and waste-derived liquids, with their marked environmental efficiency devoted to developing novel sustainable materials. Therefore, Environmentally Friendly Polymers and Polymer Composites provides an overview to scientists of the potential of these environmentally friendly materials and helps engineers to apply these new materials for industrial purposes.
PLA --- PCL --- TPS --- biopolymer blends --- mechanical properties --- compostable plastics --- green composites --- natural fillers --- poly(butylene succinate) (PBS) --- almond shell flour (ASF) --- poly (lactic acid) (PLA) --- poly(butylene succinate-co-adipate) (PBSA) --- binary blends --- shape memory behaviour --- polymer‒matrix composites (PMCs) --- thermomechanical --- electron microscopy --- compatibilizers --- poly(lactic acid) (PLA) --- natural fibre (NF) --- nano-hydroxyapatite (nHA) --- flammability --- crab shell --- chitin --- spherical microgels --- reverse micelle --- gelation --- chitosan (CS) --- anti-oxidant --- anti-apoptotic activity --- rotenone --- Parkinson’s disease (PD) --- composite materials --- hybrid resin --- natural reinforcement --- non-uniformities --- mechanical behavior --- antifungal activity --- dendrimer --- Origanum majorana L. essential oil --- Phytophthora infestans --- maleinized linseed oil MLO --- poly(lactic acid) --- diatomaceous earth --- biocomposites --- active containers --- polymer mixtures --- blends --- cashew nut shell liquid (CNSL) --- polypropylene --- high impact polystyrene --- compatibilization --- PHB --- PHBV --- rice husk --- biosustainability --- waste valorization --- bacterial cellulose --- natural rubber --- reinforcing --- biodegradable polymers --- Arboform --- epoxidized oil --- maleinized linseed oil --- toughness --- thermal stability --- pectin --- food packaging --- active compounds --- agro-waste residues --- circular economy --- graphene oxide --- size selection --- sodium alginate --- bio-based polymers --- biodegradable polyesters --- wood plastic composites --- natural additives and fillers --- composites characterization --- bioplastics manufacturing
Listing 1 - 5 of 5 |
Sort by
|